Cefazolin Qilu 1 g prašak za otopinu za injekciju/infuziju
| Name | Cefazolin Qilu 1 g prašak za otopinu za injekciju/infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-572695905 |
| Active Substance | cefazolinnatrij |
| Composition | jedna bočica sadrži 1 g cefazolina (u obliku cefazolinnatrija) |
| Pharmaceutical Form | Prašak za otopinu za injekciju / infuziju |
| Manufacturer | Kymos S.L., Cerdanyola del Valles, Barcelona, Španjolska MIAS Pharma Limited, Portmarnock, Irska Tillomed Malta Limited, San Gwann, Malta |
| Marketing Authorisation Holder | Qilu Pharma Spain S.L., Paseo de la Castellana 40, planta 8, Madrid, Španjolska |
| Marketing Authorisation Date | 16.03.2023 |
| MA Period of Validity | 16.03.2028 |
| Classification Number | UP/I-530-09/22-01/263 |
| Registration Number | 381-12-01/70-23-07 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J01DB04 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
